Caused by protozoa of the genus Trypanosoma
Affects all domesticated animals
Tsetse-transmitted Trypanosomiasis
Major Veterinary Species: T. congolense, T. vivax, T. brucei brucei, T. simiae
Zoonotic Species (People are predominant host): T. brucei rhodesiense, T. brucei gambiense
Domestic animals act as reservoirs for human infections
Transmission:
Primarily cyclic via tsetse flies (genus Glossina)
Can be mechanical by biting flies (including tsetse)
T. vivax is found outside tsetse-infested areas, carried mechanically by biting flies like Tabanus spp
Geographic Distribution: Africa (South, eastern, West, central, including Uganda), Central and South America, West Indies
Tsetse flies restricted to Africa (~15°N to 29°S)
Animals Mainly Affected:
Cattle, sheep, goats: T. congolense, T. vivax, T. brucei brucei (in order of importance)
Pigs: T. simiae (most important)
Dogs and cats: T. brucei (probably most important)
Horses and camels: Order of importance difficult to assign; T. vivax and T. simiae listed
Wild animals: Various species susceptible
Pathogenesis:
Infected tsetse inoculate metacyclic trypanosomes into skin
Reside in skin for days, cause localized inflammation (chancres)
Enter lymph and lymph nodes, then bloodstream
Divide rapidly by binary fission
T. congolense attach to endothelial cells, localize in capillaries/small blood vessels
T. brucei species and T. vivax invade tissues and cause damage
Immune response is vigorous; immune complexes cause inflammation (contributes to fever/signs)
Antibodies kill trypanosomes via surface coat glycoproteins
Antigenic variation: Trypanosomes switch variable surface-coat glycoproteins to evade immunity
Results in persistence of organism
Prevents protective vaccine development
Permits reinfections
Clinical Findings and Lesions:
Severity varies with animal species/age and trypanosome species
Incubation: 1–4 weeks
Primary signs: intermittent fever, anemia, weight loss
Cattle: Usually chronic course with high mortality, especially with poor nutrition/stress
May recover if low tsetse challenge, but stress causes relapse
Necropsy (nonspecific):
Acute cases: Extensive petechiation (serosal membranes), swollen lymph nodes/spleen
Chronic cases: Swollen lymph nodes, serous atrophy of fat, anemia
Diagnosis:
Presumptive: Anemic animal in poor condition in endemic area
Confirmation: Demonstrating trypanosomes
Stained blood smears
Wet mounts (especially buffy coat of centrifuged PCV tube - most sensitive rapid method, look for motile parasites)
Serologic testing: Measures antibody
More suitable for herd/area screening than individual diagnosis
Rapid agglutination tests: Detect circulating species-specific antigens
Available for individual and herd diagnosis, reliability varies
Molecular techniques (PCR): Detection and differentiation
Developed but not generally available for routine field use
Exclude other causes of anemia/weight loss (babesiosis, anaplasmosis, theileriosis, haemonchosis) by examining stained blood smear
Treatment:
Use of chemotherapeutics
Examples: Diminazene aceturate, Homidium bromide/chloride, Isometamidium chloride, Quinapyramine sulfate/dimethylsulfate, Suramin
Most have a narrow therapeutic index; correct dose is essential
Drug resistance occurs and should be considered
Control:
Reduction of tsetse fly populations
Frequent spraying/dipping of animals
Aerial/ground spraying of insecticides on breeding areas
Insecticide-impregnated screens/targets
Bush clearing and habitat removal
Sterile Insect Technique (SIT) used successfully in Zanzibar
Pan African Tsetse and Trypanosomiasis Eradication Campaign (PATTEC)
Use of prophylactic drugs
Animals given drugs prophylactically in high-challenge areas
Drug resistance must be monitored
Enhancing host resistance
Some breeds of cattle/water buffalo have innate resistance
Resistance may be lost due to poor nutrition/heavy challenge
Ideally achieved by combining methods (reduce challenge + enhance resistance + prophylactic drugs)
Surra
Caused by T. evansi
Transmission: Primarily by other biting flies (e.g., Tabanus spp), probably from interrupted feedings
Geographic Distribution: Within and outside tsetse areas; North Africa, Middle East, Asia, Far East, Central and South America
Affected Animals: Essentially camels and horses, but all domestic animals susceptible
Severity: Can be fatal, particularly in camels, horses, and dogs
Reservoirs: Other animals where T. evansi appears nonpathogenic, a few wild animals
Pathogenesis, clinical findings, lesions, diagnosis: Similar to tsetse-transmitted trypanosomes
Treatment: Similar to tsetse-transmitted trypanosomes; Melarsomine dichlorhydrate listed specifically for T. evansi in camels
Dourine
Caused by T. equiperdum
Transmission: Chronic venereal disease, transmitted during coitus
Geographic Distribution: Mediterranean coast of Africa, Middle East, southern Africa, South America, probably wider
Affected Animals: Horses
Clinical Findings: Develop over weeks/months
Early: Mucopurulent discharge (urethra in stallions, vagina in mares), gross edema of genitalia
Later: Characteristic skin plaques (2–10 cm), progressive emaciation
Mortality: 50%–70% in untreated cases
Diagnosis:
Demonstration of trypanosomes: Difficult (urethral/vaginal discharges, skin plaques, peripheral blood), may require centrifugation
Complement fixation test: Can detect infected horses
Only reliable where T. evansi or T. brucei are absent due to common antigens
ELISA test: May become available
Treatment: Horses may be treated in endemic areas (drugs listed in table)
Control (when eradication required):
Strict control of breeding
Elimination of stray horses
Euthanasia mandatory for infected horses identified by complement fixation test
Chagas Disease (American Trypanosomiasis)
Caused by T. cruzi
Type: Zoonotic, vector-borne disease
Transmission:
Mainly by triatomine bugs (genera Triatoma, Rhodnius, Panstrongylus) - "kissing bug," "assassin bug," etc.
Infective metacyclic trypomastigotes shed in insect feces
Consumption of infected bugs or materials contaminated with insect feces (major mode in insectivorous animals like dogs)
Opossums: Can complete entire life cycle without vector; shed infective trypomastigotes in feces or urine
Transplacental
Blood transfusions and organ transplant
Geographic Distribution:
Endemic in 21 countries of South/Central America and Mexico
Increasingly reported in southern USA
Emerging disease in Europe (Spain, Switzerland, France, Italy, Germany, England) due to migration
Affected Animals: All mammals susceptible (>100 species)
Best recognized in dogs and people
Dogs serve as a major domestic reservoir
Domestic pigs and cats can be infected, but limited reservoir role
Wildlife reservoirs: Opossums, armadillos, raccoons, woodrats, nonhuman primates
Avian species are not susceptible
Pathogenesis:
Metacyclic trypomastigotes enter bloodstream, actively invade many cell types
Exit parasitophorous vacuole, become nonflagellated amastigotes
Intracellular amastigotes divide
Transform back into trypomastigotes, lyse the cell
Released trypomastigotes invade new cells
Tropism for cardiac and smooth muscle, but found in numerous other tissues
Clinical Findings and Lesions: Divided into acute and chronic phases
Incubation: 5–42 days before acute disease
Acute phase:
Asymptomatic or nonspecific febrile illness
Chancre at parasite entry site
Dogs may have regional/generalized lymphadenopathy, anorexia, lethargy, vomiting, diarrhea, hepatomegaly or splenomegaly
Rarely, acute clinical myocarditis
Parasitemia peaks 2-3 weeks post-infection, dissipates as organism moves to tissues
Chronic phase:
Latent phase: Months to years
Symptomatic chronic disease: Generalized weakness or sudden death
Common presentation in dogs: Right-side congestive heart failure
Can progress to myocarditis, arrhythmias, bilateral cardiac dilation
Histologic findings in cardiac muscle: unruptured pseudocysts (no inflammation) or ruptured pseudocysts (inflammation)
Death secondary to heart failure is common
Diagnosis:
Visualization of organism: Direct examination of blood smear (acute phase)
T. cruzi is C-shaped, extracellular, single flagellum on Giemsa stain
Detection of DNA: PCR or culture (uncommon in field)
Antibody detection: Primary importance during chronic phase
Tests: Immunochromographic "dipstick," immunofluorescent antibody (IFAT), ELISA
Cross-reaction with Leishmania antibodies can occur
Recommend testing with at least two different methodologies or antigens
Tissue analysis (chronic phase): PCR for DNA, immunohistochemical analysis for amastigotes
Treatment:
Benznidazole: Drug of choice (5–10 mg/kg/day, PO, for 2 months in dogs)
Nifurtimox can also be used
Note: In the USA, these drugs lack FDA approval and require CDC permission as investigational protocols
Symptomatic treatment for heart failure and arrhythmias recommended
Control:
No vaccine available
Focuses on preventing disease transmission
Vector control: Applying pesticides, decreasing vector attraction to dwellings (turning off outdoor lighting)
Discourage breeding of positive bitches
Screening of blood donors recommended
Disinfection of contaminated surfaces (10% bleach or 70% ethanol)
Infected dead insects remain a source for varying times depending on temperature
Reservoirs: Dogs, people, wildlife
Nonpathogenic Trypanosomes
Species: Trypanosoma theileri or similar (Theileri group)
T. melophagium (sheep)
T. theodori (goats) - may be a synonym for T. melophagium
Transmission:
T. theileri: Contamination after cycle in tabanid flies
T. melophagium: Transmitted by the sheep ked
Affected Animals: Cattle, domestic and wild buffalo, wild ungulates (T. theileri); sheep (T. melophagium), goats (T. theodori)
Distribution: Worldwide (T. theileri, T. melophagium)
Parasitemia: Usually subpatent
Diagnosis: May be seen in blood smear or hemocytometer chamber examined for pathogenic protozoa
Pathogenicity: Never proven experimentally